Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced ...
Ring also recently rolled out “Familiar Faces,” a feature that uses facial recognition to identify specific people in the ...
Massive compute capabilities enable a whole new way of manipulating and using data, and a potential bonanza for AI data centers.
Researchers discovered a compound, Mic-628, that resets the body clock, helping daily rhythms shift earlier and recover from ...
Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track ...
Hosted on MSN
Kansas City Chiefs find potential fill-in quarterback for Patrick Mahomes if he isn't ready to go by Week 1
The Kansas City Chiefs may need a reliable backup quarterback as Patrick Mahomes recovers from his knee injury. Although Mahomes aims to be ready by Week 1, the possibility of a delayed return means ...
WASHINGTON, DC, UNITED STATES, January 22, 2026 /EINPresswire.com/ — Homesage.ai today announced the launch of AI-powered investment potential scores, a proprietary ...
SAN FRANCISCO – Jonathan Kuminga is skilled and talented, a basketball superstar-in-waiting who is being subjected to malicious detention by his employers. Once liberated from the Warriors, he will be ...
UW-Madison researchers have found potential new treatments for a rare pediatric brain cancer each year that has a median survival time of less than a year. The research involved thousands of fruit ...
To start 2025, Kansas City Chiefs tight end Travis Kelce entered the season in fantastic shape and maintained top form, even as the team struggled. Despite remaining one of the NFL’s best tight ends, ...
James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...
Barreling toward the end of its cash runway, GRI Bio has shared phase 2a data in idiopathic pulmonary fibrosis (IPF) and made the case for further development of its potentially disease-modifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results